FibroGen Inc Working Capital to Net Assets Ratio
FibroGen Inc working capital to net assets ratio. FibroGen Inc (FGEN) has a Working Capital to Net Assets ratio of 557.3% as of September 2025. Working capital of $97.45 Million (current assets of $133.42 Million minus current liabilities of $35.97 Million) is measured against net assets of $17.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check FibroGen Inc (FGEN) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of FibroGen Inc (2012–2024)
Working capital to net assets ratio of FibroGen Inc from 2012 to 2024. This chart shows how FibroGen Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 557.3%, reflecting working capital of $97.45 Million against net assets of $17.48 Million USD. See FibroGen Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
FibroGen Inc Working Capital to Net Assets Ratio by Year (2012–2024)
FibroGen Inc working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for FibroGen Inc from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see FGEN total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -34.4% | $63.20 Million | $-183.63 Million | $196.51 Million | $133.31 Million | ▲ +35.8 pp |
| 2023 | -70.2% | $113.89 Million | $-162.20 Million | $331.56 Million | $217.67 Million | ▲ +14744.9 pp |
| 2022 | -14815.1% | $219.26 Million | $-1.48 Million | $492.83 Million | $273.56 Million | ▼ -14923.6 pp |
| 2021 | 108.5% | $248.56 Million | $229.11 Million | $474.06 Million | $225.50 Million | ▼ -25.6 pp |
| 2020 | 134.1% | $591.92 Million | $441.45 Million | $755.11 Million | $163.19 Million | ▲ +22.1 pp |
| 2019 | 112.0% | $599.75 Million | $535.41 Million | $702.49 Million | $102.75 Million | ▼ -1.7 pp |
| 2018 | 113.7% | $600.98 Million | $528.47 Million | $690.01 Million | $89.03 Million | ▼ -1.6 pp |
| 2017 | 115.3% | $671.71 Million | $582.45 Million | $748.97 Million | $77.26 Million | ▲ +0.3 pp |
| 2016 | 115.0% | $201.39 Million | $175.11 Million | $266.52 Million | $65.12 Million | ▲ +47.2 pp |
| 2015 | 67.8% | $133.38 Million | $196.82 Million | $200.56 Million | $67.18 Million | ▲ +11.5 pp |
| 2014 | 56.3% | $135.48 Million | $240.68 Million | $198.24 Million | $62.75 Million | ▼ -42.4 pp |
| 2013 | 98.7% | $106.16 Million | $107.60 Million | $143.64 Million | $37.48 Million | ▲ +74.8 pp |
| 2012 | 23.8% | $29.12 Million | $122.18 Million | $52.80 Million | $23.68 Million | — |